1/46
Comprehensive vocabulary flashcards covering the functional organization, central control, neurotransmission, receptor subtypes, pharmacology, and metabolic regulation of the autonomic nervous system.
Central Nervous System (CNS)
The division of the nervous system consisting of the brain and spinal cord, protected by the bony structures of the skull and spine.
Peripheral Nervous System (PNS)
The nervous system division consisting of 31 pairs of spinal nerves and 12 pairs of cranial nerves, responsible for communication between the CNS and the rest of the body.
Sensory Division (Afferent Nerves)
Nerves that conduct impulses from receptors to the CNS, responsible for gathering sensory information from the body.
Somatic Sensory Fibres
Afferent fibres that conduct sensory information to the CNS from the skin, muscles, and joints.
Visceral Sensory Fibres
Afferent fibres that conduct sensory information to the CNS from the internal organs.
Motor Division (Efferent Nerves)
Nerves that conduct regulatory impulses from the CNS to effector structures, including muscles, glands, and adipose tissue.
Somatic Nervous System
An efferent motor division that conducts nerve impulses from the CNS directly to skeletal muscles under voluntary control.
Autonomic Nervous System (ANS)
An efferent motor division that conducts impulses from the CNS to smooth muscles, the heart, endocrine glands, and adipose tissue under involuntary control.
Sympathetic Nervous System
The branch of the ANS that mediates the 'fight-or-flight' response, acting antagonistically to the parasympathetic division.
Parasympathetic Nervous System
The branch of the ANS that mediates the 'rest-and-digest' (or 'rest & relax') response, acting antagonistically to the sympathetic division.
Systemic Homeostasis (ANS Parameters)
A dynamic physiological balance maintained by the ANS alongside endocrine, immune, and behavioral systems, defined by set points such as body temperature of 37∘C, blood pressure of 90mmHg, pH of 7.4, and osmolarity of 300mOsm.
CNS Control Centers of the ANS
The three principal brain structures that govern the involuntary functions of the ANS and initiate autonomic, endocrine, and behavioral responses: the hypothalamus, pons, and medulla oblongata.
Autonomic Ganglion
A peripheral cluster of neuronal cell bodies situated outside the CNS (the functional equivalent of a CNS nucleus) where preganglionic neurons synapse with postganglionic neurons.
Preganglionic Neuron
The first efferent neuron in an autonomic pathway, originating in the CNS and projecting its axon to an autonomic ganglion.
Postganglionic Neuron
The second efferent neuron in an autonomic pathway, having its cell body located within an autonomic ganglion and sending an unmyelinated axon to target effector tissues.
Divergence (in Autonomic Pathways)
An anatomical arrangement in autonomic ganglia where a single preganglionic axon branches to synapse with multiple postganglionic neurons.
Sympathetic Autonomous Centers
Preganglionic neuronal cell bodies located in the lateral grey column of the spinal cord from segments Th1–Th12 and L1–L3.
Parasympathetic Autonomous Centers
Preganglionic neuronal cell bodies located in the brainstem nuclei of cranial nerves III, VII, IX, and X, as well as the lateral grey column of the sacral spinal cord (S2–S4).
Enteric Nervous System
An intrinsic autonomous division of the nervous system consisting of neuronal networks in Auerbach's (myenteric) and Meissner's (submucosal) intramural plexuses.
Adrenal Medulla (ANS Function)
A specialized neuroendocrine structure that acts as a modified sympathetic ganglion, directly innervated by preganglionic sympathetic fibers.
Chromaffin Cell
A modified postganglionic sympathetic neuron within the adrenal medulla that releases adrenaline (epinephrine, E) and noradrenaline (norepinephrine, NE) directly into the circulation.
Parasympathetic Pathway Architecture
Autonomic circuits characterized by long preganglionic fibers, terminal ganglia located within or near target organs, short postganglionic fibers, and acetylcholine (ACh) utilized at both synapses.
Sympathetic Pathway Architecture
Autonomic circuits characterized by short preganglionic fibers, ganglia positioned in sympathetic trunks along the spine, acetylcholine (ACh) at the ganglionic synapse, and norepinephrine (NE) at the postganglionic target synapse.
Autonomic Varicosities
Series of swellings along the branched terminals of postganglionic autonomic axons containing neurotransmitter vesicles and mitochondria, releasing transmitters across target cells.
Nicotinic Receptors (N)
Ionotropic cholinergic receptors found in autonomic ganglia, neuromuscular junctions, and the adrenal medulla; binding of 2 ACh molecules induces postsynaptic membrane depolarization.
Nicotinic Receptor Pharmacology
Pharmacological profile of nicotinic receptors characterized by the agonist nicotine and antagonists hexamethonium (in the ANS) and curare (at neuromuscular junctions).
Muscarinic Receptors (M)
Metabotropic cholinergic receptors operating via second messenger pathways (IP3 and DAG) that respond to acetylcholine in parasympathetic target tissues.
Muscarinic M1 Receptor
A postsynaptic muscarinic receptor subtype whose binding to ACh increases K+ conductivity and causes depolarization; selectively blocked by pirenzepine.
Muscarinic M2 Receptor
A presynaptic muscarinic receptor subtype whose binding to ACh increases K+ conductivity and causes hyperpolarization; selectively blocked by scopolamine.
Muscarinic Receptor Pharmacology
Pharmacological profile of muscarinic receptors featuring agonists muscarine and oxotremorine, and general antagonist atropine.
Adrenergic Receptor α1
A postsynaptic adrenergic receptor on salivary glands and vascular, uterine, bronchial, and GI smooth muscles; acts via IP3, shows stronger response to NE than E (NE>E), stimulated by phenylephrine, and blocked by prazosin and phentolamine.
Adrenergic Receptor α2
An adrenergic receptor located mainly presynaptically (and postsynaptically on mast cells and thrombocytes) that inhibits adenylyl cyclase, lowering cAMP; shows stronger response to NE than E, stimulated by clonidine, and blocked by yohimbine.
Adrenergic Receptor β1
An adrenergic receptor located primarily in the heart that acts via cAMP; exhibits equal responsiveness to norepinephrine and epinephrine (NE=E), stimulated by dobutamine, and blocked by atenolol.
Adrenergic Receptor β2
A non-innervated adrenergic receptor located in bronchial muscles that acts via cAMP; exhibits stronger response to epinephrine than norepinephrine (NE<E), stimulated by fenoterol, and blocked non-specifically by propranolol.
Adrenergic Receptor β3
An adrenergic receptor subtype localized in adipose tissue that mediates metabolic effects via cAMP, exhibiting a stronger response to norepinephrine than epinephrine (NE>E).
Cotransmission
Synaptic transmission in the ANS based on the joint interaction of a classical low molecular weight neurotransmitter and a peptide co-transmitter.
Neuromodulation
The local secretion of regulatory factors (such as VIP, PHI, enkephalins, substance P, CCK, serotonin, ATP, NPY, PACAP, GnRH, and dopamine) that control the amount of presynaptically released neurotransmitter.
Autonomic Counterregulation
Cross-talk at neuroeffector junctions where sympathetic and parasympathetic terminals modulate each other's release via presynaptic receptors (such as α2 and muscarinic receptors).
Up-Regulation
An increase in cell surface receptor density occurring in response to low ligand exposure, resulting in increased sensitivity and a stronger cellular response.
Down-Regulation
A decrease in cell surface receptor density following prolonged excessive stimulation, leading to reduced sensitivity and a diminished cellular response.
Early Denervation Hypersensitivity
An increased sensitivity of target tissues developing 2–3 days after denervation caused by the failure of presynaptic neurotransmitter reuptake.
Delayed Denervation Hypersensitivity
An increased sensitivity of target tissues developing 2–3 weeks after denervation caused by the up-regulation of postsynaptic receptors.
Mechanisms of Norepinephrine Inactivation
The four physiological routes of terminating NE action: neuronal uptake (inhibited by cocaine, reserpine), tissue uptake (inhibited by glucocorticoids), diffusion into blood, and enzymatic degradation.
COMT and MAO Type A
The two primary enzymes degrading norepinephrine: catechol-O-methyltransferase (COMT) and monoamine oxidase (MAO) type A, the latter being blocked by drugs like amphetamine and imipramine.
Choline Acetyltransferase
The neuronal enzyme responsible for synthesizing acetylcholine from acetyl-CoA and choline inside cholinergic terminals.
Acetylcholinesterase (AChE)
The enzyme located in the synaptic cleft and target tissues that rapidly degrades acetylcholine into acetic acid and choline.
Postganglionic Efferent Fibres (ANS)
The terminal nerve fibres running from autonomic ganglia to target effector tissues, characterized by being unmyelinated.